Stephen A. Cockle
University of Alberta
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Stephen A. Cockle.
Structure | 1994
Penelope E. Stein; Amechand Boodhoo; Glen D. Armstrong; Stephen A. Cockle; Michel H. Klein; Randy J. Read
BACKGROUND Pertussis toxin is an exotoxin of the A-B class produced by Bordetella pertussis. The holotoxin comprises 952 residues forming six subunits (five different sequences, S1-S5). It plays an important role in the development of protective immunity to whooping cough, and is an essential component of new acellular vaccines. It is also widely used as a biochemical tool to ADP-ribosylate GTP-binding proteins in the study of signal transduction. RESULTS The crystal structure of pertussis toxin has been determined at 2.9 A resolution. The catalytic A-subunit (S1) shares structural homology with other ADP-ribosylating bacterial toxins, although differences in the carboxy-terminal portion explain its unique activation mechanism. Despite its heterogeneous subunit composition, the structure of the cell-binding B-oligomer (S2, S3, two copies of S4, and S5) resembles the symmetrical B-pentamers of the cholera toxin and Shiga toxin families, but it interacts differently with the A-subunit. The structural similarity is all the more surprising given that there is almost no sequence homology between B-subunits of the different toxins. Two peripheral domains that are unique to the pertussis toxin B-oligomer show unexpected structural homology with a calcium-dependent eukaryotic lectin, and reveal possible receptor-binding sites. CONCLUSION The structure provides insight into the pathogenic mechanisms of pertussis toxin and the evolution of bacterial toxins. Knowledge of the tertiary structure of the active site forms a rational basis for elimination of catalytic activity in recombinant molecules for vaccine use.
Nature Structural & Molecular Biology | 1994
Penelope E. Stein; Amechand Boodhoo; Glen D. Armstrong; Louis D. Heerze; Stephen A. Cockle; Michel H. Klein; Randy J. Read
Archive | 1988
Michel H. Klein; Heather A. Boux; Stephen A. Cockle; Sheena M. Loosmore; Gavin Zealey
Journal of Molecular Biology | 1996
Bart Hazes; Amechand Boodhoo; Stephen A. Cockle; Randy J. Read
Infection and Immunity | 1993
Sheena M. Loosmore; G. Zealey; Stephen A. Cockle; Heather A. Boux; Pele Chong; R. Yacoob; M. Klein
Journal of Biological Chemistry | 1993
Xiamao Li; Fernando L. Rock; Pele Chong; Stephen A. Cockle; A. Keating; H. Ziltener; M. Klein
Archive | 1994
Randy J. Read; Penelope E. Stein; Stephen A. Cockle; Raymond P. Oomen; Sheena Aurora Loosmore; Michel H. Klein; Glen D. Armstrong; Bart Hazes
Archive | 1992
Michel H. Klein; Heather A. Boux; Stephen A. Cockle; Sheena M. Loosmore; Gavin Zealey
Archive | 1991
Michel H. Klein; Heather A. Boux; Stephen A. Cockle; Sheena M. Loosmore; Gavin Zealey
Molecular Immunology | 1991
Sheena M. Loosmore; Stephen A. Cockle; Gavin Zealey; Heather A. Boux; Kimberley Phillips; Raafat Fahim; Michel Klein